-
40B+
Healthcare transactions processed annually -
2.3M+
Active prescribers -
305M+
Active patients -
98%
Healthcare transactions with an identified payer, plan, or PBM
Why Symphony Health?
Revolutionising healthcare with expertly integrated US data for improved patient outcomes
Data strategy
that ensures business continuity.
Data strength
from 110+ sources with an average of 20+ years partnership.
Data connections
3 out of 4 patients with Rx linked to diagnosis.
Data optimisation
Tokenised open & closed claims asset.
Data fit for purpose
Project-based data partnerships for unique business questions.
Data solutions
Consulting + technology expertise for exclusive alternatives.
Our commitment to data excellence
At Symphony Health, we use data to create solutions for virtually any business that needs to answer questions about any step of the patient health journey. We believe the evidence-based future of the U.S. healthcare system centres around understanding the patient. Our focus is to help you to generate actionable insights from multiple dimensions of the patient journey, focused on key therapeutic areas.
Intelligence
- 40+ years of experience in the industry
- Expert-led discovery and assessment through a consultative approach
- Right blend of business and data consulting
- Data strategy aligned to your unique needs
Integrity
- 110+ data sources with 20+ years average partnership
- Expanding strategic data partnerships
- Privacy-compliant
- Ensuring business continuity through data strategy
Integration
- 40+B transactions processed annually
- Providing a trusted vs. unified, longitudinal view of patients across multiple touchpoints
- Token validation through a curated US patient master
- Extensive Synoma® healthcare & consumer data ecosystem
For more information
Please contact us directly for more information or to speak with an expert.
Our solutions
Insights Hub: Thought leadership by category
Open & closed claims:

Whitepaper: The claims conundrum: Integrating openness and precision for competitive advantage.
With an abundance of healthcare data available, life sciences organisations have an unprecedented opportunity to make more informed decisions at critical business milestones. This whitepaper, explores how leaders can maximise the value of healthcare claims data by choosing the most suitable claims data foundation from which to build.

Webinar: From Fragmented to Fluid
A deep dive into claims data innovation. This session is a behind-the-scenes look at the practical applications of open, closed, and integrated claims data as foundational options to a successful data strategy.

Blog: An integrated approach for deeper insight with both open and closed claims data
In this blog, we will summarise open and closed as standalone foundations but will also explore a third option of integrating both open and closed claims in a singular dataset.
Data continuity & transparency:

Blog: Data Transparency: Variances in patient and claims counts explained
This blog explains how Symphony Health’s commitment to data transparency ensures clients can confidently interpret and utilise their refreshed datasets.

Blog: Unlocking the value of transparent healthcare data
In this blog, we'll explore how transparency in healthcare data can unlock its full potential. Discover why transparency matters and how Symphony Health’s approach ensures you get the most accurate, actionable insights.

Case study: Breakthrough patient reach with data-powered disease education campaign
In Q1 2024, Underscore Marketing launched an unbranded campaign to educate patients with a rare lung disease. Using data-driven, privacy-safe strategies, it raised awareness and introduced a soon-to-launch treatment.

Article: Med Ad News publication: Why continuity and transparency are key to maximize the value of healthcare data
This article explores why continuity and transparency in healthcare data matter. It offers key questions to assess your data provider and shows how clear, contextual data supports smarter, long-term decisions.

Webinar: Navigating the complexity of real-world healthcare data: choosing the right tools at the right time
From evaluating your asset to sizing markets across multiple indications to merger and acquisition opportunities, the business questions life sciences professionals face are varied and complex. Learn more about what organisations need to understand about choosing the right offering at the right time.
Data integration:
.jpg?crop=yes&w=1429&h=750&a=6,0&itok=KekfRy8h)
Whitepaper: The triad of trust: Navigating real-world healthcare data integration
This whitepaper delves into the critical need for organisations to develop robust frameworks for integrating healthcare data seamlessly to drive better patient outcomes and organisational success while upholding patient privacy and compliance standards.

Webinar: Beyond the token: Why your healthcare data and integration strategy matters
Listen to experts talk about the need for new data integration strategies in healthcare domain to support the massive digitisation efforts taking place in the industry.

Blog: Validated tokens: The key to following the patient journey
Increasingly, sponsors are finding value in integrating clinical trial data with real-world data and precision medicine data to follow patients through the continuum of care, beyond their trial participation.
Inflation Reduction Act (IRA):

Blog: Medicare Part D Price Negotiations update: Widespread impact on the industry
The Inflation Reduction Act (IRA) and resulting Medicare Part D price negotiations promise widespread impact on the industry. For the first time in history, the government is empowered to negotiate drug pricing directly with manufacturers.

Blog: Navigating the impacts of the Inflation Reduction Act (IRA): Strategic considerations for pharma
Explore the Inflation Reduction Act’s key points of impact on pharmaceutical companies and considerations to strategically evolve with the coming changes.
_drug_pill_thumbnail.jpg?crop=yes&w=370&h=194&a=0,0&itok=BbyoTqtt)
Blog: Tallying the TrOOPs: Tracking cost implications under IRA Part D reforms
Get insights into how the 2025 IRA reforms change how Medicare patients accumulate out-of-pocket spend and how the cost burden shifts between stakeholders.
_drug_pill_thumbnail.jpg?crop=yes&w=370&h=194&a=0,0&itok=5Yi_VOKX)
Blog: Subtler scopes: Where IRA drug negotiations meet Part D redesigns
Understand how the intersections of the IRA’s price negotiations, discounts and out-of-pocket caps will impact your drug strategy.
Social determinants of health (SDoH):

Blog: How pharma can use social determinants of health to address health equity
Effectively utilising SDoH data can inform more patient-centric practices and precise commercial strategies to reach underserved and underrepresented communities and improve real-world outcomes including diagnosis, treatment and adherence journeys.

Blog: SDoH data for efficient, patient-centred clinical trials
The social determinants of health (SDoH) are a key component of understanding and delivering better outcomes for patients.

Blog: SDoH data analysis for proactive outcome improvement: A multilayered approach
Social determinants of health affect patients in widely variable ways, and proper, multi-layered analysis is required to gain actionable insight into patient healthcare consumption and behaviour to optimise brand strategy and deliver better solutions and services to patients.
Posters
Explore our posters showcasing Symphony Health's latest research on topics like social determinants of health, diabetes treatment adherence, and the impact of drug shortages, presented at major conferences.
.jpg?crop=yes&w=1365&h=1365&a=342,0&itok=oFYeJ0Tl)